QuidelOrtho Launches VITROS 450 Chemistry System to Expand Diagnostic Access

The VITROS 450 Chemistry System incorporates MicroSlide technology and remote diagnostic capabilities to support consistent performance and simplified laboratory operations

QuidelOrtho Corporation has launched its VITROS 450 Chemistry System across key global markets, including China, Asia-Pacific, Europe, the Middle East and Africa, and Latin America, aiming to expand access to high-quality clinical chemistry testing in low-volume and community-based laboratories.

The next-generation chemistry analyser is designed to support laboratories operating in resource-constrained environments, including rural clinics, urban satellite laboratories and facilities within larger diagnostic networks. Its compact footprint and waterless operation enable laboratories to perform testing without requiring plumbing or drains, addressing common infrastructure limitations.

The VITROS 450 Chemistry System incorporates MicroSlide technology and remote diagnostic capabilities to support consistent performance and simplified laboratory operations. Its intuitive design and streamlined maintenance requirements are intended to help laboratory teams with varying levels of experience deliver reliable results efficiently.

The system also focuses on operational sustainability. Its waterless design eliminates water consumption during operation, while the overall system design aims to reduce energy use and operational waste. These features could benefit laboratories seeking to optimise resources while maintaining testing quality.

According to QuidelOrtho, the system is designed to deliver high-quality results aligned with Six Sigma standards and is supported by the company's service capabilities. Its integration into the broader VITROS portfolio is also intended to help diagnostic networks standardise testing processes and maintain consistency across multiple laboratory sites.

The launch marks an expansion of QuidelOrtho's clinical chemistry offerings, particularly for facilities that require reliable diagnostic testing but face limitations related to space, water availability or staffing. By bringing compact chemistry testing capabilities closer to patients, the company aims to support timely clinical decision-making across diverse healthcare settings.

The VITROS 450 Chemistry System forms part of QuidelOrtho's broader strategy to deliver accessible, reliable diagnostic solutions to laboratories and healthcare providers worldwide.